why choose us

First received: September 25, 2023

Clinical Trial: Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral Microtia

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Microtia

Study Type: INTERVENTIONAL


Official Title: A Phase 1/2, Multi-Center, Open-Label, Single-Arm Safety, Tolerability, and Efficacy Study of an Auricle and Wedge Subcutaneous Implant Combination Product (AUR-201) in Patients With Unilateral M

Brief Summary: AUR-201 is indicated for the treatment of Grade II, III, or IV unilateral microtia in patients 8 to 29 years of age.

Read more